Related Business Topics
Company Profiles
Alexion Pharmaceuticals, Inc.. The Group's principal activity is to develop therapeutic products for the treatment of severe diseases including cardiovascular and autoimmune disorders and cancer. The products include Pexelizumab, Eculizumab, Uni...
Develops scientific discoveries into medical products and licenses the products to multinational pharmaceutical companies
Antigenics Inc.. The Group's principal activities are to develop technologies and products to treat cancers and infectious diseases. The Group primarily develops Oncophage (R). Lead development programs include immunotherapeutics that are based ...
Astrazeneca Plc. The Group's Principal Activities Are The Research, Development And Marketing of Medicines For Serious Health Conditions. The Group Focused on Seven Important Areas of Healthcare Such as Gastrointestinal, Cardiovascular, Oncology...
AutoImmune Inc.. The Group's principal activity is to develop and market pharmaceutical products for the treatment of autoimmune and other cell-mediated inflammatory diseases. The products are based on the principles of mucosal tolerance. Mucosa...
Avant Immunotherapeutics Incorporated. The Group's principal activity is to discover, develop and market pharmaceutical products to prevent and treat diseases. The Group is developing a portfolio of vaccines against viral and bacterial diseases,...
BioTransplant Incorporated. The Group's principal activity is to develop and commercialize therapeutics and therapeutic devices and regimens. The products are intended to suppress undesired immune responses and enhance the body's ability to acce...
Bristol-Myers Squibb Company. The Group's principal activities are to produce and distribute pharmaceuticals and other healthcare related products. The Group operates in three reportable segments: Pharmaceuticals, Nutritionals and Other Healthca...
DEVELOPS, MANUFACTURES & MARKETS DIAGNOSTIC PRODUCTS FOR SEROLOGIC DIAGNOSIS OF VASCULAR DISEASES & AUTOIMMUNE DISEASES
Hollis-Eden Pharmaceuticals, Inc.. The Company's principal activity is to develop a series of proprietary Immune Regulating Hormones (IRHs) for the treatment of immune system and metabolic disorders. The purpose of IRH therapy is to direct, thro...
Immunex Corporation. The Group's principal activity is to develop, discover, manufacture and market innovative therapeutic products. Major products of the Group include leukine, novantrone, thioplex, methotrexate, amicar, levoprome, enbrel-TM-, ...
Quidel Corporation. The Group's principal activity is to develop, manufacture & market point-of-care rapid diagnostics for detection of human medical conditions & illness. The products of the Group are pregnancy, infectious diseases, osteoporosi...
SEE ALSO:
Profile
Stallergenes. The Group's principal activity is the research of allergies, and the development, production and distribution of allergen extracts for the curative treatment of allergic rhinitis and asthma. The Group's products include items for d...
Viragen International, Inc.. The Group's principal activities are to research, develop, manufacture and market a natural human alpha interferon product indicated for treatment of a broad range of viral and malignant diseases. The Group produces ...
